Immune checkpoint molecules efficiently regulate T cell activation, and thus enable tumor cells to evade the immune system, for example by hijacking the PD-1/ PD-L1 interaction to downregulate effector T cells [25, 26]. The gene discussed is PDCD1; the disease is neoplasm.